Search form

Scroll To Top

lenacapavir

CVS pharmacy window customer interaction
Health

CVS Health denies coverage for  breakthrough HIV drug, committing 'clear violation' of ACA

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory factors."

Ian L. Haddock founder of the normal anomaly
Health

Why injectable PrEP will be a gamechanger for Black LGBTQ+ Americans

Ian L. Haddock, founder of the Normal Anomaly Initiative, participated in the trials for lenacapavir, an FDA-approved drug that he hopes will create a brighter future for communities of color.

​The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV by 96 percent
Health

FDA approves breakthrough drug that reduces risk of contracting HIV by 96 percent

Otherwise known by its generic name lenacapavir (LEN), Yeztugo has been approved after nearly eliminating the spread of HIV among trial patients.